(COCO) Vita Coco - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US92846Q1076
Stock: Coconut Water, Coconut Oil, Coconut Milk, Protein Drink, Packaged Water
Total Rating 69
Risk 92
Buy Signal 1.71
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 40.2% |
| Relative Tail Risk | -7.95% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.04 |
| Alpha | 33.25 |
| Character TTM | |
|---|---|
| Beta | 0.739 |
| Beta Downside | 0.573 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.55% |
| CAGR/Max DD | 1.54 |
Description: COCO Vita Coco January 14, 2026
The Vita Coco Company Inc. (NASDAQ: COCO) manufactures and sells coconut-based beverages-including coconut water, coconut oil, juice, milk, and a protein-infused fitness drink (PWR LIFT)-under its flagship brand and the Ever & Ever water label, while also providing private-label products to retailers across North America, Europe, the Middle East, Africa, and APAC.
In FY 2023 the company reported roughly $1.1 billion in revenue, reflecting a compound annual growth rate of about 12 % since 2020, driven largely by a 45 % YoY increase in e-commerce sales and expanding placement in mass-market and food-service channels. Key macro drivers include rising consumer demand for functional, low-sugar beverages and the broader 5 % CAGR growth of the non-alcoholic drinks sector, while supply-chain exposure to coconut-growing regions (primarily the Philippines and Indonesia) remains a material risk.
For a deeper quantitative dive, explore ValueRay’s COCO analytics dashboard to see the latest valuation metrics and scenario analyses.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 69.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -8.97 > 1.0 |
| NWC/Revenue: 49.22% < 20% (prev 46.49%; Δ 2.73% < -1%) |
| CFO/TA 0.13 > 3% & CFO 58.0m > Net Income 69.2m |
| Net Debt (-189.7m) to EBITDA (80.2m): -2.36 < 3 |
| Current Ratio: 3.43 > 1.5 & < 3 |
| Outstanding Shares: last quarter (59.9m) vs 12m ago 0.95% < -2% |
| Gross Margin: 36.00% > 18% (prev 0.40%; Δ 3560 % > 0.5%) |
| Asset Turnover: 149.6% > 50% (prev 140.1%; Δ 9.49% > 0%) |
| Interest Coverage Ratio: -14.47 > 6 (EBITDA TTM 80.2m / Interest Expense TTM -5.49m) |
Altman Z'' 8.85
| A: 0.65 (Total Current Assets 423.3m - Total Current Liabilities 123.5m) / Total Assets 461.3m |
| B: 0.48 (Retained Earnings 222.5m / Total Assets 461.3m) |
| C: 0.19 (EBIT TTM 79.4m / Avg Total Assets 407.2m) |
| D: 1.63 (Book Value of Equity 223.7m / Total Liabilities 137.6m) |
| Altman-Z'' Score: 8.85 = AAA |
Beneish M -2.83
| DSRI: 1.07 (Receivables 103.4m/78.6m, Revenue 609.3m/494.9m) |
| GMI: 1.11 (GM 36.00% / 39.80%) |
| AQI: 0.75 (AQ_t 0.04 / AQ_t-1 0.05) |
| SGI: 1.23 (Revenue 609.3m / 494.9m) |
| TATA: 0.02 (NI 69.2m - CFO 58.0m) / TA 461.3m) |
| Beneish M-Score: -2.83 (Cap -4..+1) = A |
What is the price of COCO shares?
As of February 03, 2026, the stock is trading at USD 55.73 with a total of 747,813 shares traded.
Over the past week, the price has changed by +1.57%, over one month by +4.25%, over three months by +36.53% and over the past year by +50.54%.
Over the past week, the price has changed by +1.57%, over one month by +4.25%, over three months by +36.53% and over the past year by +50.54%.
Is COCO a buy, sell or hold?
Vita Coco has received a consensus analysts rating of 3.90.
Therefore, it is recommended to buy COCO.
- StrongBuy: 4
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the COCO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 58 | 4.1% |
| Analysts Target Price | 58 | 4.1% |
| ValueRay Target Price | 81.2 | 45.7% |
COCO Fundamental Data Overview January 31, 2026
P/E Trailing = 47.2826
P/E Forward = 28.8184
P/S = 5.0823
P/B = 9.5397
Revenue TTM = 609.3m USD
EBIT TTM = 79.4m USD
EBITDA TTM = 80.2m USD
Long Term Debt = 3000 USD (from longTermDebt, last fiscal year)
Short Term Debt = 5000 USD (from shortTermDebt, last quarter)
Debt = 14.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -189.7m USD (from netDebt column, last quarter)
Enterprise Value = 2.91b USD (3.10b + Debt 14.0m - CCE 203.7m)
Interest Coverage Ratio = -14.47 (Ebit TTM 79.4m / Interest Expense TTM -5.49m)
EV/FCF = 54.90x (Enterprise Value 2.91b / FCF TTM 52.9m)
FCF Yield = 1.82% (FCF TTM 52.9m / Enterprise Value 2.91b)
FCF Margin = 8.69% (FCF TTM 52.9m / Revenue TTM 609.3m)
Net Margin = 11.35% (Net Income TTM 69.2m / Revenue TTM 609.3m)
Gross Margin = 36.00% ((Revenue TTM 609.3m - Cost of Revenue TTM 390.0m) / Revenue TTM)
Gross Margin QoQ = 37.66% (prev 36.30%)
Tobins Q-Ratio = 6.30 (Enterprise Value 2.91b / Total Assets 461.3m)
Interest Expense / Debt = -39.15% (Interest Expense -5.49m / Debt 14.0m)
Taxrate = 21.76% (6.68m / 30.7m)
NOPAT = 62.1m (EBIT 79.4m * (1 - 21.76%))
Current Ratio = 3.43 (Total Current Assets 423.3m / Total Current Liabilities 123.5m)
Debt / Equity = 0.04 (Debt 14.0m / totalStockholderEquity, last quarter 323.7m)
Debt / EBITDA = -2.36 (Net Debt -189.7m / EBITDA 80.2m)
Debt / FCF = -3.58 (Net Debt -189.7m / FCF TTM 52.9m)
Total Stockholder Equity = 289.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 16.98% (Net Income 69.2m / Total Assets 461.3m)
RoE = 23.90% (Net Income TTM 69.2m / Total Stockholder Equity 289.3m)
RoCE = 27.43% (EBIT 79.4m / Capital Employed (Equity 289.3m + L.T.Debt 3000 ))
RoIC = 21.46% (NOPAT 62.1m / Invested Capital 289.3m)
WACC = 8.60% (E(3.10b)/V(3.11b) * Re(8.64%) + (debt cost/tax rate unavailable))
Discount Rate = 8.64% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.32%
[DCF Debug] Terminal Value 67.53% ; FCFF base≈60.7m ; Y1≈39.8m ; Y5≈18.2m
Fair Price DCF = 8.97 (EV 321.4m - Net Debt -189.7m = Equity 511.1m / Shares 56.9m; r=8.60% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 50.86 | EPS CAGR: -11.54% | SUE: -3.81 | # QB: 0
Revenue Correlation: 78.47 | Revenue CAGR: 21.96% | SUE: 4.0 | # QB: 4
EPS next Quarter (2026-03-31): EPS=0.33 | Chg30d=-0.015 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=1.63 | Chg30d=+0.247 | Revisions Net=+3 | Growth EPS=+38.8% | Growth Revenue=+13.7%
P/E Forward = 28.8184
P/S = 5.0823
P/B = 9.5397
Revenue TTM = 609.3m USD
EBIT TTM = 79.4m USD
EBITDA TTM = 80.2m USD
Long Term Debt = 3000 USD (from longTermDebt, last fiscal year)
Short Term Debt = 5000 USD (from shortTermDebt, last quarter)
Debt = 14.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -189.7m USD (from netDebt column, last quarter)
Enterprise Value = 2.91b USD (3.10b + Debt 14.0m - CCE 203.7m)
Interest Coverage Ratio = -14.47 (Ebit TTM 79.4m / Interest Expense TTM -5.49m)
EV/FCF = 54.90x (Enterprise Value 2.91b / FCF TTM 52.9m)
FCF Yield = 1.82% (FCF TTM 52.9m / Enterprise Value 2.91b)
FCF Margin = 8.69% (FCF TTM 52.9m / Revenue TTM 609.3m)
Net Margin = 11.35% (Net Income TTM 69.2m / Revenue TTM 609.3m)
Gross Margin = 36.00% ((Revenue TTM 609.3m - Cost of Revenue TTM 390.0m) / Revenue TTM)
Gross Margin QoQ = 37.66% (prev 36.30%)
Tobins Q-Ratio = 6.30 (Enterprise Value 2.91b / Total Assets 461.3m)
Interest Expense / Debt = -39.15% (Interest Expense -5.49m / Debt 14.0m)
Taxrate = 21.76% (6.68m / 30.7m)
NOPAT = 62.1m (EBIT 79.4m * (1 - 21.76%))
Current Ratio = 3.43 (Total Current Assets 423.3m / Total Current Liabilities 123.5m)
Debt / Equity = 0.04 (Debt 14.0m / totalStockholderEquity, last quarter 323.7m)
Debt / EBITDA = -2.36 (Net Debt -189.7m / EBITDA 80.2m)
Debt / FCF = -3.58 (Net Debt -189.7m / FCF TTM 52.9m)
Total Stockholder Equity = 289.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 16.98% (Net Income 69.2m / Total Assets 461.3m)
RoE = 23.90% (Net Income TTM 69.2m / Total Stockholder Equity 289.3m)
RoCE = 27.43% (EBIT 79.4m / Capital Employed (Equity 289.3m + L.T.Debt 3000 ))
RoIC = 21.46% (NOPAT 62.1m / Invested Capital 289.3m)
WACC = 8.60% (E(3.10b)/V(3.11b) * Re(8.64%) + (debt cost/tax rate unavailable))
Discount Rate = 8.64% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.32%
[DCF Debug] Terminal Value 67.53% ; FCFF base≈60.7m ; Y1≈39.8m ; Y5≈18.2m
Fair Price DCF = 8.97 (EV 321.4m - Net Debt -189.7m = Equity 511.1m / Shares 56.9m; r=8.60% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 50.86 | EPS CAGR: -11.54% | SUE: -3.81 | # QB: 0
Revenue Correlation: 78.47 | Revenue CAGR: 21.96% | SUE: 4.0 | # QB: 4
EPS next Quarter (2026-03-31): EPS=0.33 | Chg30d=-0.015 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=1.63 | Chg30d=+0.247 | Revisions Net=+3 | Growth EPS=+38.8% | Growth Revenue=+13.7%